Am Fam Physician. 2013;88(9):566
Author disclosure: No relevant financial affiliations.
Original Article: Caring for Latino Patients
Issue Date: January 1, 2013
See additional reader comments at: https://www.aafp.org/afp/2013/0101/p48.html
TO THE EDITOR: We read this article with great interest. However, the author did not mention Chagas disease among the special medical conditions that disproportionately affect persons from Central and South America.
Chagas disease is caused by Trypanosoma cruzi, a protozoan parasite transmitted principally by bloodsucking insects of the subfamily Triatominae1 that typically live in cracks in the walls of mud and straw houses in rural Latin American communities. Transmission can also occur congenitally and by laboratory accidents, contamination of food with feces of triatomines, and transfusion or transplantation of infected blood or organs.1
Acute infection with T. cruzi is usually asymptomatic and is followed by a chronic asymptomatic phase that, in about one-third of cases, leads to severe organ involvement (cardiomyopathy and/or intestinal megasyndromes) after 10 to 30 years.1 The infection may reactivate and cause severe manifestations in immunosuppressed patients.1
Chronic Chagas disease can be diagnosed through serologic testing, whereas parasitologic and molecular testing is useful for acute, congenital, and reactivated infections.1 Antitrypanosomal treatment is recommended for patients with acute, congenital, or reactivated infections, and for patients younger than 18 years who have chronic disease. Antiparasitic treatment should generally be offered to adults without advanced heart disease because it appears to slow the development and progression of Chagas disease cardiomyopathy; it generally should not be offered to patients who have advanced chagasic cardiomyopathy with congestive heart failure.5 Health care professionals should be aware of Chagas disease to provide appropriate care to Latino patients and help stop transmission of the disease.